Pascale Jolliet
- Pharmacology top 1%
- Molecular Biology
- Cellular and Molecular Neuroscience top 5%
- Infectious Diseases top 5%
- Epidemiology top 10%
- Co-authors
- Éric DaillyMichel BourinCaroline Victorri‐VigneauG. VeyracDenis J. DavidMartine HascoëtGuillaume DeslandesFrançois Raffi
- Topics
- HIV/AIDS drug development and treatment (20 papers)HIV Research and Treatment (17 papers)Schizophrenia research and treatment (17 papers)
- Cited by
- ToxicologyPharmacologyVirology
- Partner nations
- FranceUnited StatesCanada
In The Last Decade
Pascale Jolliet
159 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 146
- Pharmacology 659
- Molecular Biology 413
- Cellular and Molecular Neuroscience 404
- Infectious Diseases 370
- Epidemiology 326
Countries citing papers authored by Pascale Jolliet
This map shows the geographic impact of Pascale Jolliet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascale Jolliet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascale Jolliet more than expected).
Fields of papers citing papers by Pascale Jolliet
This network shows the impact of papers produced by Pascale Jolliet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascale Jolliet. The network helps show where Pascale Jolliet may publish in the future.
Co-authorship network of co-authors of Pascale Jolliet
This figure shows the co-authorship network connecting the top 25 collaborators of Pascale Jolliet. A scholar is included among the top collaborators of Pascale Jolliet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascale Jolliet. Pascale Jolliet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 2 | |
| 4 | 11 | |
| 5 | 23 | |
| 6 | 2 | |
| 7 | 6 | |
| 8 | 25 | |
| 9 | 38 | |
| 10 | 1 | |
| 11 | 4 | |
| 12 | 45 | |
| 13 | 5 | |
| 14 | 8 | |
| 15 | 18 | |
| 16 | 29 | |
| 17 | 67 | |
| 18 | [Characteristics of hypersensitivity syndrome to lamotrigine: review of one case reported in the Regional Center of Pharmacovigilance of Nantes]. | 14 |
| 19 | [Arthralgia associated with mirtazapine]. | 1 |
| 20 | 2 |
About Pascale Jolliet
Pascale Jolliet is a scholar working on Toxicology, Geriatrics and Gerontology and Virology, having authored 165 papers that have together received 2.7k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (20 papers), HIV Research and Treatment (17 papers) and Schizophrenia research and treatment (17 papers). The work is most often cited by research in Toxicology (192 citations), Pharmacology (659 citations) and Virology (184 citations). Pascale Jolliet has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Éric Dailly, Michel Bourin, Caroline Victorri‐Vigneau, G. Veyrac, Denis J. David, Martine Hascoët, Guillaume Deslandes, François Raffi, Régis Bouquié and Marie Grall‐Bronnec. Their work appears in journals such as PLoS ONE, FEBS Letters and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.